Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02210689
Recruitment Status : Completed
First Posted : August 7, 2014
Last Update Posted : March 19, 2015
Sponsor:
Collaborator:
Watson Laboratories, Inc.
Information provided by (Responsible Party):
Actavis Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2014
Actual Study Completion Date : December 2014